seed
Stage
2
Investors
About
Eugit Therapeutics develops tissue-targeting therapies by combining computational genomics, immunology, and synthetic biology to create precision treatments.
Explore Eugit Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.